Singapore has transitioned to a state of endemic COVID-19. In line with the stepping down of COVID-19-related measures, HSA will no longer be receiving applications for non-PSAR authorised / unregistered COVID-19 vaccines under the Special Access Route for Unauthorised COVID-19 Vaccines from 31 May 2023 onwards.
Thereafter, healthcare institutions may apply through the Special Access Route for Patient’s Use if there is an unmet medical need for a non-PSAR authorised or unregistered COVID-19 vaccine that is listed for emergency use (EUL) by WHO, for use on patients under the care of the healthcare institution.